Zuryn

University of Queensland researchers have received two $3 million grants from the National Health and Medical Research Council (NHMRC) to accelerate knowledge and treatment of Alzheimer’s disease, and to improve gynaecological cancer treatment.

Dr Anne Hahn and Associate Professor Steven Zuryn have discovered a mechanism in DNA that regulates how disease-causing mutations are inherited, providing a promising therapeutic avenue to stop the onset of heritable and age-related diseases.

Associate Professor Steven Zuryn and Dr Michael Dai at the Queensland Brain Institute have discovered that a protein called ATSF-1 controls a fine balance between the creation of new mitochondria and the repair of damaged mitochondria.

A ‘’perfect storm’’ of genetic mutations, toxic proteins and a defect in natural cell recycling could lead to treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

Researchers are a step closer to unravelling the role of small nucleic acid fragments found in each of our cells.

Scientists have shed more light on the way a key toxic protein in Alzheimer’s disease damages brain cells.

QBI researchers have discovered where the highest rate of genetic mutations occurs in mitochondrial DNA.